Not complicated here. Anybody with a basic clue on the science can see this does not talk about DCVax-L.
Further, one might listen to LL. She says repeatedly how unique tumor micromanagement in GBM is a reason why DCvax-L works. Again, the exact opposite of tissue agnostic.